Early Clinical Trials Expertise
SGS has built up a unique experience in infectious diseases with over 40 years of providing industry with early phase clinical trial solutions, including First-In-Human studies, QT/QTc prolongation, human challenge testing, biosimilars and complex PK/PD studies.
For a faster, targeted patient recruitment across the Americas and Europe, clients can rely on SGS for: • Extensive database of investigators, subject matter experts and key opinion leaders with in-depth knowledge of infectious disease pathologies and access to relevant populations
• Specific skill-sets to successfully execute studies in anti-influenza, RSV, HIV, HBV/HCV as well as malaria drug and vaccines plus delivery devices • Discovery team and expertise in a wide range of respiratory diseases (asthma, COPD, COVID) • A favorable regulatory environment in Belgium with very short Phase I trial approval timelines (14 working days)
Made with FlippingBook. PDF to flipbook with ease